Data / Form D filings / Trellis Bioscience, Inc.
Trellis Bioscience, Inc.: Form D filings
Trellis Bioscience, Inc., a biotechnology company in Redwood City, CA, filed 4 Form D notices with the SEC in 2026. The latest, on October 21, 2026, reports $22.9 million sold of an offering with no set size to 88 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 702 Marshall Street Suite 301, Redwood City, CA, 94063
- Phone
- (408) 772-8049
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1162015
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 21 | New notice | Indefinite | $22,892,056 | 88 | Apr 29 | sec.gov | |
| Oct 21 | New notice | Indefinite | $985,000 | 6 | Jun 1 | sec.gov | |
| Oct 21 | New notice | Indefinite | $1,350,000 | 9 | Apr 20 | sec.gov | |
| Oct 21 | New notice | Indefinite | $4,094,500 | 27 | Oct 4 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nora Mende | Executive Officer | Chief Financial Officer |
| Larry Kauvar | Executive Officer | Chief Science Officer |
Other biotechnology companies in California that filed recently
- Theravie Pharma, Inc. $750,000 · Oct 19
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
- Lionheart Health, Inc. $387,500 · Oct 7
Every Form D from the week of Oct 19 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trellis Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.